News

Novo’s Ozempic linked to rare cases of serious eye disorder, EU regulator says
This is the first time a regulator has confirmed the side effect. Read more at straitstimes.com. Read more at straitstimes.com.
Medical Dialogues20h
EMA flags rare vision risk with Semaglutide- a active substance in Ozempic, Rybelsus, Wegovy
European Medicines Agency (EMA)'s safety committee (PRAC) has concluded its review of medicines containing semaglutide ...